<?xml version='1.0'?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:atom="http://www.w3.org/2005/Atom" >
<channel>
	<title><![CDATA[BOL: Translational Bioinformatics: Transforming 300 Billion Points of Data]]></title>
	<link>https://bioinformaticsonline.com/videolist/watch/2699/translational-bioinformatics-transforming-300-billion-points-of-data?</link>
	<atom:link href="https://bioinformaticsonline.com/videolist/watch/2699/translational-bioinformatics-transforming-300-billion-points-of-data?" rel="self" type="application/rss+xml" />
	<description><![CDATA[]]></description>
	
	<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/videolist/watch/2699/translational-bioinformatics-transforming-300-billion-points-of-data</guid>
	<pubDate>Tue, 20 Aug 2013 19:03:47 -0500</pubDate>
	<link>https://bioinformaticsonline.com/videolist/watch/2699/translational-bioinformatics-transforming-300-billion-points-of-data</link>
	<title><![CDATA[Translational Bioinformatics: Transforming 300 Billion Points of Data]]></title>
	<description><![CDATA[<iframe width="" height="" src="https://www.youtube-nocookie.com/embed/o4KNG7nd938" frameborder="0" allowfullscreen></iframe>Translational Bioinformatics: Transforming 300 Billion Points of Data into Diagnostics, Therapeutics, and New Insights into Disease      
      
Air date:  Wednesday, June 20, 2012, 3:00:00 PM
Time displayed is Eastern Time, Washington DC Local  
 
Description:  There is an urgent need to translate genome-era discoveries into clinical utility, but the difficulties in making bench-to-bedside translations haven't been well described. The nascent field of translational bioinformatics may help. Dr. Butte's lab at Stanford University builds and applies tools that convert more than 300 billion points of molecular, clinical, and epidemiological data (measured by researchers and clinicians over the past decade) into diagnostics, therapeutics, and new insights into disease. Dr. Butte, a bioinformatician and pediatric endocrinologist, will highlight his lab's work on using publicly available molecular measurements to find new uses for drugs, discovering new treatable mechanisms of disease in type 2 diabetes, and evaluating patients presenting with whole genomes sequenced. 

The NIH Wednesday Afternoon Lecture Series includes weekly scientific talks by some of the top researchers in the biomedical sciences worldwide. 

For more information, visit: 
The NIH Director's Wednesday Afternoon Lecture Series  
Author:  Atul Butte, M.D., Ph.D., Stanford University  
Runtime:  01:07:42  
Permanent link:  http://videocast.nih.gov/launch.asp?17321]]></description>
	
</item>

</channel>
</rss>